These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34061209)

  • 1. Identifying enhancement-based staging markers on baseline MRI in patients with colorectal cancer liver metastases undergoing intra-arterial tumor therapy.
    Ghani MA; Fereydooni A; Chen E; Letzen B; Laage-Gaupp F; Nezami N; Deng Y; Gan G; Thakur V; Lin M; Papademetris X; Schernthaner RE; Huber S; Chapiro J; Hong K; Georgiades C
    Eur Radiol; 2021 Dec; 31(12):8858-8867. PubMed ID: 34061209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D Quantitative tumour burden analysis in patients with hepatocellular carcinoma before TACE: comparing single-lesion vs. multi-lesion imaging biomarkers as predictors of patient survival.
    Fleckenstein FN; Schernthaner RE; Duran R; Sohn JH; Sahu S; Zhao Y; Hamm B; Gebauer B; Lin M; Geschwind JF; Chapiro J
    Eur Radiol; 2016 Sep; 26(9):3243-52. PubMed ID: 26762942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying Staging Markers for Hepatocellular Carcinoma before Transarterial Chemoembolization: Comparison of Three-dimensional Quantitative versus Non-three-dimensional Imaging Markers.
    Chapiro J; Duran R; Lin M; Schernthaner RE; Wang Z; Gorodetski B; Geschwind JF
    Radiology; 2015 May; 275(2):438-47. PubMed ID: 25531387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?
    Sahu S; Schernthaner R; Ardon R; Chapiro J; Zhao Y; Sohn JH; Fleckenstein F; Lin M; Geschwind JF; Duran R
    Radiology; 2017 Jun; 283(3):883-894. PubMed ID: 27831830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver.
    Chapiro J; Duran R; Lin M; Schernthaner R; Lesage D; Wang Z; Savic LJ; Geschwind JF
    Eur Radiol; 2015 Jul; 25(7):1993-2003. PubMed ID: 25636420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of the BCLC Staging System for Locoregional Therapy for Hepatocellular Carcinoma by Using Quantitative Tumor Burden Imaging Biomarkers at MRI.
    Borde T; Nezami N; Laage Gaupp F; Savic LJ; Taddei T; Jaffe A; Strazzabosco M; Lin M; Duran R; Georgiades C; Hong K; Chapiro J
    Radiology; 2022 Jul; 304(1):228-237. PubMed ID: 35412368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Tumor Burden as a Biomarker for Patient Survival with Neuroendocrine Tumor Liver Metastases Undergoing Intra-Arterial Therapies: A Single-Center Retrospective Analysis.
    Miszczuk M; Chapiro J; Do Minh D; van Breugel JMM; Smolka S; Rexha I; Tegel B; Lin M; Savic LJ; Hong K; Georgiades C; Nezami N
    Cardiovasc Intervent Radiol; 2022 Oct; 45(10):1494-1502. PubMed ID: 35941241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late gadolinium MRI enhancement of colorectal liver metastases is associated with overall survival among nonsurgical patients.
    Cheung HMC; Kim JK; Hudson J; Coburn N; Karanicolas PJ; Law C; Milot L
    Eur Radiol; 2019 Jul; 29(7):3901-3907. PubMed ID: 30937587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of baseline volumetric multiparametric MR imaging in neuroendocrine liver metastases treated with transarterial chemoembolization.
    Luo Y; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Zarghampour M; Khoshpouri P; Ameli S; Li Z; Hu D; Kamel IR
    Eur Radiol; 2019 Oct; 29(10):5160-5171. PubMed ID: 30877462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yttrium-90 radioembolization for unresectable hepatocellular carcinoma: predictive modeling strategies to anticipate tumor response and improve patient selection.
    Lüdemann W; Kahn J; Pustelnik D; Hardt J; Böning G; Jonczyk M; Amthauer H; Gebauer B; Hamm B; Wieners G
    Eur Radiol; 2022 Jul; 32(7):4687-4698. PubMed ID: 35230518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
    Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Imaging Biomarkers for
    Schobert I; Chapiro J; Nezami N; Hamm CA; Gebauer B; Lin M; Pollak J; Saperstein L; Schlachter T; Savic LJ
    J Nucl Med; 2019 Aug; 60(8):1066-1072. PubMed ID: 30655331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volumetric Enhancing Tumor Burden at CT to Predict Survival Outcomes in Patients with Neuroendocrine Liver Metastases after Intra-arterial Treatment.
    Assouline J; Cannella R; Porrello G; de Mestier L; Dioguardi Burgio M; Raynaud L; Hentic O; Cros J; Tselikas L; Ruszniewski P; Vullierme MP; Vilgrain V; Duran R; Ronot M
    Radiol Imaging Cancer; 2023 Jan; 5(1):e220051. PubMed ID: 36607243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 3D quantitative tumor analysis for predicting overall survival after conventional chemoembolization of intrahepatic cholangiocarcinoma.
    Rexha I; Laage-Gaupp F; Chapiro J; Miszczuk MA; van Breugel JMM; Lin M; Konstantinidis M; Duran R; Gebauer B; Georgiades C; Hong K; Nezami N
    Sci Rep; 2021 Apr; 11(1):9337. PubMed ID: 33927226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
    Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transarterial chemoembolization in soft-tissue sarcoma metastases to the liver - the use of imaging biomarkers as predictors of patient survival.
    Chapiro J; Duran R; Lin M; Mungo B; Schlachter T; Schernthaner R; Gorodetski B; Wang Z; Geschwind JF
    Eur J Radiol; 2015 Mar; 84(3):424-430. PubMed ID: 25542065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE.
    Schobert IT; Savic LJ; Chapiro J; Bousabarah K; Chen E; Laage-Gaupp F; Tefera J; Nezami N; Lin M; Pollak J; Schlachter T
    Eur Radiol; 2020 Oct; 30(10):5663-5673. PubMed ID: 32424595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of ADC measurements in predicting overall survival in patients undergoing
    Alis D; Durmaz ESM; Gulsen F; Bas A; Kabasakal L; Sager S; Numan F
    Clin Imaging; 2019; 57():124-130. PubMed ID: 31220677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting early necrosis of colorectal liver metastases using volumetric enhancement on baseline MRI and oil deposition on post-cTACE unenhanced CT.
    Hazhirkarzar B; Tang H; Ghadimi M; Baghdadi A; Motaghi M; Wu Q; Shaghaghi M; Kamel I
    Abdom Radiol (NY); 2021 Oct; 46(10):4610-4618. PubMed ID: 34089068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis.
    Chapiro J; Wood LD; Lin M; Duran R; Cornish T; Lesage D; Charu V; Schernthaner R; Wang Z; Tacher V; Savic LJ; Kamel IR; Geschwind JF
    Radiology; 2014 Dec; 273(3):746-58. PubMed ID: 25028783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.